Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The frailty index (FI) has been reported as a useful measure for assessing premorbid conditions in stroke patients; however, its significance in evaluating post-stroke status remains unclear.

Aims: This study aims to clarify the role of FI as a tool for assessing post-stroke conditions.

Methods: This retrospective cohort study included stroke patients admitted to an acute-care hospital. The FI, based on the cumulative deficit model and comprising comorbidities, symptoms, and functional limitations, was assessed using 33 items at discharge from the acute-care hospital. The primary outcome was the mRS at three months post-onset. Multiple logistic regression was performed with poor functional outcomes as the dependent variable and mRS at discharge, FI at discharge, and both as explanatory variables. The cutoff value of FI for poor functional outcomes was also determined using a receiver operating characteristic (ROC) curve.

Results: A total of 241 patients with acute stroke were included in the final analysis. The median length of hospital stay was 14 days (IQR 9-20). In the adjusted model including both FI and mRS at discharge, FI at discharge was significantly associated with poor outcomes (aOR = 3.43, 95% CI = 1.66-7.09,  < 0.001). The cutoff value of FI for poor functional prognosis derived from the ROC curve was 0.288 (sensitivity 0.816, specificity 0.911).

Conclusions: Our findings indicate that post-stroke FI is independently associated with poor outcomes. It is important to incorporate FI in addition to traditional assessment tools to predict post-stroke prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10749357.2025.2553589DOI Listing

Publication Analysis

Top Keywords

functional outcomes
12
retrospective cohort
8
cohort study
8
stroke patients
8
acute-care hospital
8
poor functional
8
discharge discharge
8
discharge
5
impact post-stroke
4
post-stroke frailty
4

Similar Publications

Scrub typhus, caused by , is a zoonotic infection endemic to the Asia-Pacific region. Its severity ranges from mild illness to life-threatening complications and case fatality rate upto 30%, highlighting the importance of early diagnosis. This study analyzed the clinical profile and pregnancy outcomes of 34 pregnant women diagnosed with scrub typhus at a tertiary care and referral centre.

View Article and Find Full Text PDF

Background: Few studies have evaluated COVID-19 vaccine effectiveness (VE) in middle-income countries, particularly in eastern Europe. We aimed to estimate COVID-19 VE against SARS-CoV-2-confirmed hospitalizations and severe outcomes in Kosovo.

Methods: We conducted a test-negative case-control study using data from Kosovo's severe acute respiratory infection (SARI) sentinel surveillance system from January 2022 to June 2024.

View Article and Find Full Text PDF

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as Empagliflozin, are antidiabetic drugs that reduce glucose levels and have emerged as a promising therapy for patients with heart failure (HF), although the exact molecular mechanisms underlying their cardioprotective effects remain to be fully elucidated. The EmDia study, a randomized, double-blind trial conducted at the University Medical Center of Mainz, has confirmed the beneficial effects of Empagliflozin in HF patients after both one and twelve weeks of treatment. In this work, we aimed to assess whether changes in lipid profiles driven by Empagliflozin use in HF patients in the EmDia trial could assist in gaining a better understanding of its cardioprotective mechanisms.

View Article and Find Full Text PDF

Fighting for every beat: cardiac therapies in Duchenne muscular dystrophy.

Skelet Muscle

September 2025

Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France.

Duchenne muscular dystrophy (DMD) is a severe, progressive genetic disorder caused by mutations in the DMD gene, resulting in the absence of dystrophin-a key structural protein at the sarcolemma. As the disease progresses, cardiac involvement becomes a leading cause of morbidity and mortality. By adolescence or early adulthood, many patients develop dilated cardiomyopathy and arrhythmias.

View Article and Find Full Text PDF

Introduction: Sarcopenia is a pathologic condition frequent in aged population, leading to functional and cognitive impairment. Given the ageing of the population worldwide, the topic has generated interest in the last decades and is expected to be more relevant in the near future. This paper aims to present the mechanism of sarcopenia, the current state of knowledge regarding diagnosis and treatment and the role of sarcopenia in orthopaedic and traumatological settings.

View Article and Find Full Text PDF